FIELD: biotechnology.
SUBSTANCE: disclosed is a method for automated determination of concentration of active lysozyme in biological samples, involving preparation of standard samples from a lyophilized commercial preparation of chicken egg lysozyme for plotting a calibration curve and a standardized at wavelength of 450 nm by optical density of a suspension of a lyophilised cell culture of Micrococcus lysodeikticus from a commercial preparation. In the cells of cooled 96-well polystyrene plate placed on a cold element, standard samples of lysozyme and analyzed samples in different dilutions are added in a triplet, held for 6 minutes at +4... +8 °C, then, 150 mcl of a standardized suspension of Micrococcus lysodeikticus is added to the plate wells at room temperature and incubated for 6 minutes in a thermal shaker at +25 °C and shaking at 100 rpm; optical density of the samples is measured at wave length 450 nm on a plate photometer and the concentration of active lysozyme, mcg/ml, is calculated in accordance with the calibration curve.
EFFECT: invention provides a wider range of methods for quantitative determination of the concentration of active lysozyme in human biological fluids for clinical purposes.
1 cl, 2 dwg, 8 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING SALIVARY LYSOZYME ACTIVITY | 2000 |
|
RU2170932C1 |
METHOD FOR TREATMENT OF DIABETIC RETINOPATHY | 2021 |
|
RU2782996C1 |
METHOD FOR DETERMINING LEVEL OF BIOCOMPATABILITY OF BIFID BACTERIA AND/OR LACTIC BACTERIA STRAINS | 2018 |
|
RU2676910C1 |
METHOD FOR DETERMINATION OF LYSOZYME ACTIVITY OF BIOLOGICAL OBJECTS | 2005 |
|
RU2294373C2 |
METHOD N1 FOR PREPARING A SORBENT BASED ON COVALENT IMMOBILIZED AND CHEMICALLY MODIFIED LYSOZYME FOR SORPTION OF BACTERIAL ENDOTOXINS AND THE SORBENT ITSELF | 2019 |
|
RU2736149C1 |
METHOD FOR DETERMINING CONCENTRATION OF ANTIVIRAL DRUGS IN BIOMATERIALS OF LABORATORY ANIMALS | 2020 |
|
RU2748249C1 |
METHOD FOR BIOLOGICAL DISINFECTING OF STANDING POOLS FROM PATHOGENIC AND CONDITIONALLY PATHOGENIC MICROFLORA | 2001 |
|
RU2193531C2 |
METHOD OF LYSOCYME COVALENT IMMOBILIZATION FOR SUBSEQUENT APPLICATION OF IMMOBILIZED LYSOZYME TO REDUCE BACTERIAL POPULATION OF BIOLOGICAL FLUIDS | 2018 |
|
RU2694883C1 |
STRAIN OF HYBRID CULTURED MURINE CELLS MUS MUSCULUS L USED FOR PREPARING MONOCLONAL ANTIBODIES TO PHENOBARBITAL | 1993 |
|
RU2049817C1 |
METHOD AND KIT FOR ENZYME IMMUNOASSAY OF FUNCTIONAL ACTIVITY OF HUMAN COMPLEMENT COMPONENT C3 BY ABILITY TO BIND TO LYSOCYME | 2014 |
|
RU2571289C1 |
Authors
Dates
2024-06-03—Published
2023-09-22—Filed